Earlier today, the UCI advised Italian rider Danilo Di Luca that he is provisionally suspended. The decision to provisionally suspend Mr Di Luca was made in response to a report from the WADA accredited laboratory in Paris indicating an Adverse Analytical Finding of Recombinant EPO (CERA) in blood samples collected from him at the Giro dâ€™Italia on 20 May and 28 May 2009.
These adverse findings were a direct result of a targeted test programme conducted on Mr Di Luca using information from his biological passportâ€™s blood profile, previous test results and his race schedule.
The provisional suspension of Mr Di Luca remains in force until a hearing panel convened by the Italian Cycling Federation determines whether he has indeed committed an anti-doping rule violation under Article 21 of the UCI Anti-Doping Rules.
Mr Di Luca has the right to request and attend the analyses of both his B samples.
Under the World Anti-Doping Code and the UCI Anti-Doping Rules, the UCI is unable to provide any additional information at this time.
UCI Press Services